Form 4: DXC’s David Herzog Receives 25.7k RSU Grant

Rhea-AI Filing Summary

DXC Technology (DXC) – Form 4 insider filing: Director David L. Herzog reported the grant of 25,700 restricted stock units (RSUs) on 08 Aug 2025. Each RSU converts to one DXC common share at no cost to the director.
• Vesting: earliest of one year after grant (08 Aug 2026) or the 2026 annual shareholder meeting. Shares settle at vesting or on a deferred date selected by the director.
• Ownership after grant: 116,401 DXC shares, including unvested RSUs. All holdings are listed as direct ownership.

The filing reflects routine director compensation rather than an open-market purchase or sale; therefore it does not alter the public float or signal a viewpoint on valuation. However, the additional equity modestly aligns the director’s incentives with shareholders.

Positive

• Director’s stake increases by 25,700 potential shares, modestly improving management–shareholder alignment.

Negative

• None.

Insights

Equity Compensation Analyst

TL;DR: Routine RSU grant; neutral signal, mild alignment benefit.

Herzog received 25.7k RSUs, boosting his stake to 116.4k shares. Because no shares were purchased with personal funds and vesting extends one year, market impact is minimal. The grant size is typical for DXC’s board compensation plan and does not indicate insider conviction, but it does incrementally tie director wealth to long-term share performance. Overall, neutral from a valuation perspective.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Herzog David L

(Last) (First) (Middle)

20408 BASHAN DRIVE

SUITE 231

(Street)

ASHBURN VA 20147

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DXC Technology Co [ DXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2025		A		25,700(1)	A	$0	116,401(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2026 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.

2. Amount reported includes unvested RSUs.

Remarks:

	Matt Fawcett, Attorney-in-Fact	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many DXC shares did Director David L. Herzog acquire?

He was granted 25,700 restricted stock units, each convertible into one share.

When will the newly granted DXC RSUs vest?

They vest on the earlier of one year from grant or the 2026 annual meeting.

What is Herzog’s total DXC shareholding after the grant?

He beneficially owns 116,401 shares, including unvested RSUs.

Did the director buy or sell any DXC shares on the open market?

No. The filing only reports a stock-based compensation grant; no open-market transactions occurred.

Does this Form 4 indicate positive or negative sentiment for DXC stock?

It is generally neutral; the RSU grant is routine board compensation and not a discretionary purchase.